Loading...
Assertio Holdings, Inc.
ASRT•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.74
$-0.01(-1.27%)
Assertio Holdings, Inc. (ASRT) Financial Performance & Income Statement Overview
Review Assertio Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-17.83%
↓ 17.83%
Operating Income Growth
89.95%
↑ 89.95%
Net Income Growth
93.50%
↑ 93.50%
Operating Cash Flow Growth
-46.76%
↓ 46.76%
Operating Margin
-28.04%
↓ 28.04%
Gross Margin
69.89%
↑ 69.89%
Net Profit Margin
-25.31%
↓ 25.31%
ROE
-24.48%
↓ 24.48%
ROIC
-21.18%
↓ 21.18%
Assertio Holdings, Inc. (ASRT) Income Statement & Financial Overview
Review Assertio Holdings, Inc.'s (ASRT) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $32.18M | $29.20M | $31.13M | $32.45M |
| Cost of Revenue | $11.61M | $7.55M | $8.89M | $16.91M |
| Gross Profit | $20.57M | $21.65M | $22.24M | $15.54M |
| Gross Profit Ratio | $0.64 | $0.74 | $0.71 | $0.48 |
| R&D Expenses | $1.29M | $1.005M | $798000.00 | $733000.00 |
| SG&A Expenses | $21.42M | $16.73M | $18.39M | $18.42M |
| Operating Expenses | $34.05M | $24.70M | $25.85M | $19.16M |
| Total Costs & Expenses | $45.66M | $32.25M | $34.74M | $36.06M |
| Interest Income | $780000.00 | $887000.00 | $842000.00 | $0.00 |
| Interest Expense | $763000.00 | $761000.00 | $758000.00 | $650000.00 |
| Depreciation & Amortization | $6.71M | $6.71M | $6.71M | $5.73M |
| EBITDA | -$3.27M | $4.59M | $3.94M | $2.11M |
| EBITDA Ratio | -$0.10 | $0.16 | $0.13 | $0.07 |
| Operating Income | -$13.47M | -$3.05M | -$3.62M | -$3.62M |
| Operating Income Ratio | -$0.42 | -$0.10 | -$0.12 | -$0.11 |
| Other Income/Expenses (Net) | $2.73M | $171000.00 | $92000.00 | -$41000.00 |
| Income Before Tax | -$10.75M | -$2.88M | -$3.52M | -$4.38M |
| Income Before Tax Ratio | -$0.33 | -$0.10 | -$0.11 | -$0.13 |
| Income Tax Expense | -$273000.00 | $44000.00 | $149000.00 | $132000.00 |
| Net Income | -$10.48M | -$2.92M | -$3.67M | -$4.51M |
| Net Income Ratio | -$0.33 | -$0.10 | -$0.12 | -$0.14 |
| EPS | -$0.11 | -$0.03 | -$0.04 | -$0.05 |
| Diluted EPS | -$0.11 | -$0.03 | -$0.04 | -$0.05 |
| Weighted Avg Shares Outstanding | $95.51M | $95.35M | $95.24M | $94.98M |
| Weighted Avg Shares Outstanding (Diluted) | $95.51M | $95.35M | $95.24M | $94.98M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan